-
EP1139755
European procedure
Extract from the Register of European Patents
EP About this file: EP1139755
| EP1139755 - METHOD FOR TREATMENT OF BACTERIAL INFECTIONS WITH ONCE OR TWICE-WEEKLY ADMINISTERED RIFALAZIL [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 30.03.2007 Database last updated on 12.11.2024 | Most recent event Tooltip | 05.12.2008 | Lapse of the patent in a contracting state New state(s): CY | published on 07.01.2009 [2009/02] | Applicant(s) | For all designated states KANEKA CORPORATION 2-4, Nakanoshima 3-chome Kita-ku Osaka-shi, Osaka 530-8288 / JP | [N/P] |
| Former [2006/18] | For all designated states KANEKA CORPORATION 3-2-4, Nakanoshima, Kita-ku Osaka 530-8288 / JP | ||
| Former [2002/10] | For all designated states Kaneka Corporation 3-2-4, Nakanoshima, Kita-ku Osaka 530-8288 / JP | ||
| Former [2001/41] | For all designated states PATHOGENESIS CORPORATION Suite 150, 201 Elliot Avenue West Seattle, WA 98119 / US | Inventor(s) | 01 /
ROSE, Lynn, M. 9514 Lakeshore Boulevard, NE Seattle, WA 98115 / US | 02 /
PORUBEK, David, J. 2548 NE92ND Seattle, WA 98115 / US | 03 /
MONTGOMERY, Alan, B. 3455 Evergreen Pt. Road Bellevue, WA 98004 / US | [2001/41] | Representative(s) | Vossius & Partner Patentanwälte Rechtsanwälte mbB Siebertstrasse 3 81675 München / DE | [N/P] |
| Former [2008/35] | Vossius & Partner Siebertstrasse 3 81675 München / DE | ||
| Former [2001/41] | VOSSIUS & PARTNER Siebertstrasse 4 81675 München / DE | Application number, filing date | 99968906.0 | 16.12.1999 | [2001/41] | WO1999US30101 | Priority number, date | US19980112921P | 18.12.1998 Original published format: US 112921 P | [2001/41] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO0035408 | Date: | 22.06.2000 | Language: | EN | [2000/25] | Type: | A2 Application without search report | No.: | EP1139755 | Date: | 10.10.2001 | Language: | EN | The application published by WIPO in one of the EPO official languages on 22.06.2000 takes the place of the publication of the European patent application. | [2001/41] | Type: | B1 Patent specification | No.: | EP1139755 | Date: | 03.05.2006 | Language: | EN | [2006/18] | Type: | B9 Corrected patent specification | No.: | EP1139755 | Date: | 05.07.2006 | [2006/27] | Search report(s) | International search report - published on: | US | 02.11.2000 | (Supplementary) European search report - dispatched on: | EP | 19.11.2002 | Classification | IPC: | A01N43/40, A61K31/44, A61K31/00 | [2003/01] | CPC: |
A61K31/538 (EP,US);
A61K31/5375 (KR);
A61K31/00 (EP,US);
A61K31/70 (EP,US);
A61P1/04 (EP);
A61P11/00 (EP);
A61P31/04 (EP);
A61P31/06 (EP);
A61P31/18 (EP);
C10M101/025 (EP,US);
C10M103/06 (EP,US);
C10M105/14 (EP,US);
C10M105/24 (EP,US);
C10M107/34 (EP,US);
C10M107/36 (EP,US);
C10M111/00 (EP,US);
C10M2201/0603 (EP,US);
C10M2201/0613 (EP,US);
C10M2201/0623 (EP,US);
C10M2201/0653 (EP,US);
C10M2201/0663 (EP,US);
C10M2201/0803 (EP,US);
C10M2201/0853 (EP,US);
C10M2201/0863 (EP,US);
C10M2201/0873 (EP,US);
C10M2201/1006 (EP,US);
C10M2201/1023 (EP,US);
C10M2201/1033 (EP,US);
C10M2201/1053 (EP,US);
C10M2201/123 (EP,US);
C10M2205/143 (EP,US);
C10M2205/163 (EP,US);
C10M2205/173 (EP,US);
C10M2205/183 (EP,US);
C10M2207/0225 (EP,US);
C10M2207/1203 (EP,US);
C10M2207/1213 (EP,US);
C10M2207/1253 (EP,US);
C10M2207/163 (EP,US);
C10M2207/183 (EP,US);
C10M2207/203 (EP,US);
C10M2207/243 (EP,US);
C10M2209/1033 (EP,US);
C10M2209/1045 (EP,US);
C10M2209/1055 (EP,US);
C10M2209/1065 (EP,US);
C10M2209/1075 (EP,US);
C10M2209/1085 (EP,US);
| C-Set: |
A61K31/538, A61K2300/00 (EP,US);
A61K31/70, A61K2300/00 (US,EP) |
| Former IPC [2001/41] | A01N43/40, A61K31/44 | Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [2001/41] | Extension states | AL | Not yet paid | LT | Not yet paid | LV | Not yet paid | MK | Not yet paid | RO | Not yet paid | SI | Not yet paid | Title | German: | VERFAHREN ZUR BEHANDLUNG VON BAKTERIELLEN INFEKTIONEN DURCH einmal oder zweimal wöchentliche VERABREICHUNG VON RIFALAZIL | [2006/05] | English: | METHOD FOR TREATMENT OF BACTERIAL INFECTIONS WITH ONCE OR TWICE-WEEKLY ADMINISTERED RIFALAZIL | [2001/41] | French: | PROCEDE DE TRAITEMENT DES INFECTIONS BACTERIENNES PAR ADMINISTRATION HEBDOMADAIRE OU BI-HEBDOMADAIRE DE RIFALAZIL | [2001/41] |
| Former [2001/41] | VERFAHREN ZUR BEHANDLUNG VON BAKTERIELLEN INFEKTIONEN DURCH WOCHENDLICHE ODER ZWEIMAL WOCHENDLICHE VERABREICHUNG VON RIFALAZIL | Entry into regional phase | 09.07.2001 | National basic fee paid | 09.07.2001 | Search fee paid | 09.07.2001 | Designation fee(s) paid | 09.07.2001 | Examination fee paid | Examination procedure | 30.05.2000 | Request for preliminary examination filed International Preliminary Examining Authority: US | 09.07.2001 | Examination requested [2001/41] | 14.05.2004 | Despatch of a communication from the examining division (Time limit: M07) | 23.12.2004 | Reply to a communication from the examining division | 15.02.2005 | Despatch of a communication from the examining division (Time limit: M02) | 25.04.2005 | Reply to a communication from the examining division | 26.07.2005 | Communication of intention to grant the patent | 02.12.2005 | Fee for grant paid | 02.12.2005 | Fee for publishing/printing paid | Opposition(s) | 06.02.2007 | No opposition filed within time limit [2007/18] | Fees paid | Renewal fee | 28.12.2001 | Renewal fee patent year 03 | 30.12.2002 | Renewal fee patent year 04 | 31.12.2003 | Renewal fee patent year 05 | 31.12.2004 | Renewal fee patent year 06 | 30.12.2005 | Renewal fee patent year 07 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | CY | 03.05.2006 | IE | 18.12.2006 | MC | 31.12.2006 | [2009/02] |
| Former [2008/18] | IE | 18.12.2006 | |
| MC | 31.12.2006 | Documents cited: | Search | [X] - HIRATA TETSUO ET AL., "In Vitro and in Vivo Activities of the Benzoxazinorifamycin KRM-1648 Against Mycobacterium Tuberculosis", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, (1995), vol. 39, no. 10, pages 2295 - 303, XP002219529 [X] 1-6,14-16 * page 2299, column R, paragraph 3 * * table 5 * | International search | [X] - LENAERTS ET. AL., "Evaluation of Rifapentine in Long-Term Treatment Regimens for Tuberculosis in Mice", CAPLUS, XP002949867 | [ ] - ANTIMICROBIAL AGENTS CHEMOTHER, (1999), vol. 43, no. 10, pages 2356 - 2360 | [X] - BROOKS ET. AL., "Evaluation of Once-Weekly Therapy for Tuberculose using Isoniazid Plus Rifamycins in the Mouse Aerosol Infection Model", CAPLUS, XP002949868 | [ ] - ANTIMICROB. AGENTS CHEMOTHER, (1998), vol. 42, no. 11, pages 3047 - 3048 | [Y] - SATO ET. AL., "Effects of Half-Sized Secretory Leukocyte Protease Inhibitor and Chinese Traditional Medicines, Yokoinin and Mao-Bushi-Saishin-To, on Therapeutic Efficacies of benzoxazinorifamycin KRM-1648 against Mycobacterium Avium Complex Infection Induced in Mice", EMBASE, XP002949869 | [ ] - KEKKAKU, (1998), vol. 73, no. 8, pages 501 - 506 | [A] - R. & D. FOCUS DRUG NEWS, "Rifalazil PathoGenesis Plans Phase II Studies", DRUGNL, (19970609), XP002949870 | [Y] - GROSSET ET. AL., "Advances in Tuberculosis Preventative Theraphy", EMBASE, XP002949871 | [ ] - SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, (1997), vol. 18, no. 5, pages 449 - 457 |